The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Rare Genetic Disease Diagnosis Solution Market Research Report 2024

Global Rare Genetic Disease Diagnosis Solution Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1765394

No of Pages : 86

Ask Your Query

Synopsis
Rare genetic disease diagnosis solution refers to the process and tools used to diagnose rare genetic diseases. Rare genetic diseases are caused by variations or mutations in genes and often have a low prevalence in the population. Due to their rarity and complexity, diagnosing these diseases can be challenging and require specialized approaches.

Global Rare Genetic Disease Diagnosis Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rare Genetic Disease Diagnosis Solution market research.

Key companies engaged in the Rare Genetic Disease Diagnosis Solution industry include Retrophin, 3billion, 23andMe, Ancestry, GeneDx, Ambry Genetics, QIAGEN, Illumina and PerkinElmer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Rare Genetic Disease Diagnosis Solution were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Rare Genetic Disease Diagnosis Solution market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rare Genetic Disease Diagnosis Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Retrophin
  • 3billion
  • 23andMe
  • Ancestry
  • GeneDx
  • Ambry Genetics
  • QIAGEN
  • Illumina
  • PerkinElmer
  • Strand Life Sciences

Segment by Type

  • Genetic Testing
  • Biochemical Testing
  • Imaging and Diagnostic Procedures
  • Others

Segment by Application

  • Clinical Genetics and Pediatric Clinic
  • Newborn Screening Program
  • Research and Development
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Rare Genetic Disease Diagnosis Solution report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genetic Testing
1.2.3 Biochemical Testing
1.2.4 Imaging and Diagnostic Procedures
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rare Genetic Disease Diagnosis Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Genetics and Pediatric Clinic
1.3.3 Newborn Screening Program
1.3.4 Research and Development
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Genetic Disease Diagnosis Solution Market Perspective (2018-2029)
2.2 Rare Genetic Disease Diagnosis Solution Growth Trends by Region
2.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rare Genetic Disease Diagnosis Solution Historic Market Size by Region (2018-2023)
2.2.3 Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Region (2024-2029)
2.3 Rare Genetic Disease Diagnosis Solution Market Dynamics
2.3.1 Rare Genetic Disease Diagnosis Solution Industry Trends
2.3.2 Rare Genetic Disease Diagnosis Solution Market Drivers
2.3.3 Rare Genetic Disease Diagnosis Solution Market Challenges
2.3.4 Rare Genetic Disease Diagnosis Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Genetic Disease Diagnosis Solution Players by Revenue
3.1.1 Global Top Rare Genetic Disease Diagnosis Solution Players by Revenue (2018-2023)
3.1.2 Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Players (2018-2023)
3.2 Global Rare Genetic Disease Diagnosis Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare Genetic Disease Diagnosis Solution Revenue
3.4 Global Rare Genetic Disease Diagnosis Solution Market Concentration Ratio
3.4.1 Global Rare Genetic Disease Diagnosis Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Genetic Disease Diagnosis Solution Revenue in 2022
3.5 Rare Genetic Disease Diagnosis Solution Key Players Head office and Area Served
3.6 Key Players Rare Genetic Disease Diagnosis Solution Product Solution and Service
3.7 Date of Enter into Rare Genetic Disease Diagnosis Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Genetic Disease Diagnosis Solution Breakdown Data by Type
4.1 Global Rare Genetic Disease Diagnosis Solution Historic Market Size by Type (2018-2023)
4.2 Global Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Type (2024-2029)
5 Rare Genetic Disease Diagnosis Solution Breakdown Data by Application
5.1 Global Rare Genetic Disease Diagnosis Solution Historic Market Size by Application (2018-2023)
5.2 Global Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rare Genetic Disease Diagnosis Solution Market Size (2018-2029)
6.2 North America Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2018-2023)
6.4 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare Genetic Disease Diagnosis Solution Market Size (2018-2029)
7.2 Europe Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2018-2023)
7.4 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size (2018-2029)
8.2 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare Genetic Disease Diagnosis Solution Market Size (2018-2029)
9.2 Latin America Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country (2018-2023)
9.4 Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size (2018-2029)
10.2 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Retrophin
11.1.1 Retrophin Company Detail
11.1.2 Retrophin Business Overview
11.1.3 Retrophin Rare Genetic Disease Diagnosis Solution Introduction
11.1.4 Retrophin Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.1.5 Retrophin Recent Development
11.2 3billion
11.2.1 3billion Company Detail
11.2.2 3billion Business Overview
11.2.3 3billion Rare Genetic Disease Diagnosis Solution Introduction
11.2.4 3billion Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.2.5 3billion Recent Development
11.3 23andMe
11.3.1 23andMe Company Detail
11.3.2 23andMe Business Overview
11.3.3 23andMe Rare Genetic Disease Diagnosis Solution Introduction
11.3.4 23andMe Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.3.5 23andMe Recent Development
11.4 Ancestry
11.4.1 Ancestry Company Detail
11.4.2 Ancestry Business Overview
11.4.3 Ancestry Rare Genetic Disease Diagnosis Solution Introduction
11.4.4 Ancestry Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.4.5 Ancestry Recent Development
11.5 GeneDx
11.5.1 GeneDx Company Detail
11.5.2 GeneDx Business Overview
11.5.3 GeneDx Rare Genetic Disease Diagnosis Solution Introduction
11.5.4 GeneDx Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.5.5 GeneDx Recent Development
11.6 Ambry Genetics
11.6.1 Ambry Genetics Company Detail
11.6.2 Ambry Genetics Business Overview
11.6.3 Ambry Genetics Rare Genetic Disease Diagnosis Solution Introduction
11.6.4 Ambry Genetics Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.6.5 Ambry Genetics Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Rare Genetic Disease Diagnosis Solution Introduction
11.7.4 QIAGEN Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.7.5 QIAGEN Recent Development
11.8 Illumina
11.8.1 Illumina Company Detail
11.8.2 Illumina Business Overview
11.8.3 Illumina Rare Genetic Disease Diagnosis Solution Introduction
11.8.4 Illumina Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.8.5 Illumina Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Detail
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Rare Genetic Disease Diagnosis Solution Introduction
11.9.4 PerkinElmer Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.9.5 PerkinElmer Recent Development
11.10 Strand Life Sciences
11.10.1 Strand Life Sciences Company Detail
11.10.2 Strand Life Sciences Business Overview
11.10.3 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Introduction
11.10.4 Strand Life Sciences Revenue in Rare Genetic Disease Diagnosis Solution Business (2018-2023)
11.10.5 Strand Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock